Melinta Therapeutics Inc., a biopharmaceutical company that develops antibiotics to treat bacterial infections, filed for Chapter 11 bankruptcy protection, it said in a statement.
The Morristown New Jersey-based company said it still plans to operate following the bankruptcy filing.
